3M Drug Delivery, Spirig Pharma sign agreement; Flexible Stenting Solutions gets 510(k) clearance;

> 3M Drug Delivery Systems has signed an exclusive licensing agreement with Spirig Pharma, a Swiss maker of dermatological products. Spirig will use one of 3M's immune response modifier molecules to further its development of treatment for sun damaged skin. 3M release

> Flexible Stenting Solutions, a New Jersey-based developer of stents, has received 510(k) clearance from the FDA for an improved FlexStent Biliary Self Expanding Stent Delivery System and an expansion of Biliary stent sizes. FSS release

> The World Gold Council is, not surprisingly, quite happy that gold is being used in anti-cancer clinical trials WGC release

> Drug delivery patent application of the week: Oral Drug Delivery System for Azole, Moxifloxacin and Rifampicin Patent application

> Drug delivery abstract of the week: Applications of aptamers in nanodelivery systems in cancer, eye and inflammatory diseases Abstract

Suggested Articles

J&J has new data that should convince regulators to clear its subcutaneous Darzalex in another indication—widening its edge over a Sanofi rival.

Genentech's Port Delivery System with ranibizumab matched Lucentis eye injections in a late-stage, wet age-related macular degeneration trial.

Honeywell aims to wean the industry of its glass habit with Aclar Edge, a new line of bottles and vials made with the company's patented plastic.